We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Past and current clinical trials into therapeutic and antiviral treatments for COVID-19, how to take part, and which treatments have proven to be effective.
Find out about coronavirus (COVID-19) treatments available outside of hospital, including information on free prescriptions and lateral flow tests.
The National Treatment Agency for Substance Misuse (NTA) was established in 2001 to improve the availability, capacity and effectiveness of drug treatment. It became part of Public Health England in 2013.
Information for British people on medical support in Thailand including mental health, lists of hospitals and care homes and how the British embassy can help.
Treatment forms (T1 to T6) for use in connection with patients detained under the Mental Health Act 1983, who are in receipt of treatment for a mental disorder.
The T32 exemption allows you to treat non-hazardous pesticide washings in a biobed or biofilter.
The Medicines and Healthcare products Regulatory Agency (MHRA) has today (11 March 2024) approved the medicine quizartinib (Vanflyta) to be used alongside chemotherapy as first line treatment for adults who have acute myeloid leukaemia (AML).
Safety leaflet on topical corticosteroids and withdrawal reactions to help patients and their carers to use these medicines safely.
Licences and authorisations to import genetic material, research and diagnostic samples, trade samples and display items, and some live animals and animal products.
Guidance on referring alcohol dependent patients from hospital to specialist alcohol treatment in the hospital or in the community.
The T29 exemption allows you to treat non-hazardous pesticide washings before disposing of them to land.
Retrospective cohort study of all TB patients registered in the National Tuberculosis programme between 2006 and 2010
Get help to classify pharmaceutical products used to treat or prevent diseases or ailments (in humans or animals), including comparators used in clinical trials and placebos.
Studies in industrialised and resource-poor countries point to a higher risk of death in TB survivors
Dashboard monitoring hepatitis C virus (HCV) testing and treatment in HCV Operational Delivery Networks (ODNs) in England.
Tax and reporting rules for employers providing medical or dental treatment and insurance
New 10-year plan to expand and improve the drug and alcohol workforce published.
The epidemiology, symptoms, diagnosis and management of human T-cell lymphotropic virus types 1 and 2 (HTLV-1 and HTLV-2).
Find out about clearance applications and how to apply to HMRC for advance confirmation of an exempt distribution when a company purchases its own shares.
Guidance on Animal Test Certificates (ATCs) required to carry out the field trial of a veterinary medicine in animals (clinical trial) in the UK.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).